Introduction:Basic information about CAS 147526-32-7|Pitavastatin calcium, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Pitavastatin calcium |
|---|
| CAS Number | 147526-32-7 | Molecular Weight | 440.49 |
|---|
| Density | / | Boiling Point | 692ºC at 760 mmHg |
|---|
| Molecular Formula | C25H23FNO4.1/2Ca | Melting Point | / |
|---|
| MSDS | / | Flash Point | 372.3ºC |
|---|
Names
| Name | pitavastatin calcium |
|---|
| Synonym | More Synonyms |
|---|
Pitavastatin calcium BiologicalActivity
| Description | Pitavastatin Calcium is a potent hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor. Pitavastatin inhibits cholesterol synthesis from acetic acid with an IC50 of 5.8 nM in HepG2 cells. |
|---|
| Related Catalog | Signaling Pathways >>Autophagy >>AutophagySignaling Pathways >>Metabolic Enzyme/Protease >>HMG-CoA Reductase (HMGCR)Signaling Pathways >>Autophagy >>MitophagyResearch Areas >>Metabolic Disease |
|---|
| References | [1]. Mukhtar RY, et al. Pitavastatin. Int J Clin Pract. 2005 Feb;59(2):239-52. [2]. Kajinami K, et al. Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor. Cardiovasc Drug Rev. 2003 Fall;21(3):199-215. |
|---|
Chemical & Physical Properties
| Boiling Point | 692ºC at 760 mmHg |
|---|
| Molecular Formula | C25H23FNO4.1/2Ca |
|---|
| Molecular Weight | 440.49 |
|---|
| Flash Point | 372.3ºC |
|---|
| PSA | 186.96000 |
|---|
| LogP | 6.36680 |
|---|
| InChIKey | AMUDYCAFPCQTAZ-NRFPMOEYSA-N |
|---|
| SMILES | O=C(O)CC(O)CC(O)C=Cc1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Ca] |
|---|
| Storage condition | -20°C |
|---|
Safety Information
| Hazard Codes | Xi |
|---|
| HS Code | 2933499090 |
|---|
Customs
| HS Code | 2933499090 |
|---|
| Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|---|
Synonyms
| 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, calcium salt, (3R,5S,6E)- (2:1) |
| Pitavastatin Calcium |
| Livalo |
| Calcium bis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoate} |
| MFCD01937979 |
| UNII-IYD54XEG3W |
| Pitavastatin (Calcium) |
| calcium,(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate |
| Livazo |
| (+)-Monocalciumbis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate} |
| (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-hept-6-enoic acid |
| NK-104 |
| [3H]-Pitavastatin |
| Alipza |
| Pitavastatin hemicalcium |
| Nisvastatin |
| [14C]-Pitavastatin |
| (+)-Monocalcium bis{(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoate} |